BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 7887068)

  • 21. Use of proficiency test performance to determine clinical laboratory director qualifications.
    Howanitz PJ
    Arch Pathol Lab Med; 1988 Apr; 112(4):349-53. PubMed ID: 3355331
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Conference on the State of the Art in Quality Control Measures for Diagnostic Cytology Laboratories. Atlanta, Georgia, March 1-2, 1988. Proceedings.
    Acta Cytol; 1989; 33(4):423-90. PubMed ID: 2750428
    [No Abstract]   [Full Text] [Related]  

  • 23. HAIRVEQ 2006: evolution of laboratories' performance after different educational actions.
    Ventura M; Stramesi C; Pichini S; Ventura R; Pujadas M; Di Giovannandrea R; Zuccaro P; Pacifici R; Langohr K; de la Torre R
    Forensic Sci Int; 2008 Mar; 176(1):2-8. PubMed ID: 17980986
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Assessment of the impact of a CD4+ T-cell testing laboratory improvement program.
    Rosner E; Siragusa M; Schalla W; Cross D; Cohn R; Hearn T
    Arch Pathol Lab Med; 1998 Jun; 122(6):512-9. PubMed ID: 9625418
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [The external quality assessment for Mycobacterium tuberculosis drug susceptibility testing by proficiency testing panel to the commercial laboratories].
    Mitarai S;
    Kekkaku; 2005 Apr; 80(4):349-58. PubMed ID: 15991600
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Quality control in cytopathology. A system for simultaneous monitoring of accuracy and education and for proficiency testing.
    Carney CN
    Acta Cytol; 1984; 28(5):535-40. PubMed ID: 6385591
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Development of a newborn screening laboratory quality assurance system in Shandong, China.
    Wang W; Chen X; Zang J; He Y; Zhang P; Shen F
    Southeast Asian J Trop Med Public Health; 2003; 34 Suppl 3():36-8. PubMed ID: 15906690
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Review of Penner's criteria for proficiency testing in cytopathology: implications for the redesign of the federally mandated proficiency testing in cytopathology.
    Nagy GK; Newton LE
    Diagn Cytopathol; 2007 Jan; 35(1):61-4. PubMed ID: 17173294
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Lessons from the organization of a proficiency testing program in food microbiology by interlaboratory comparison: analytical methods in use, impact of methods on bacterial counts and measurement uncertainty of bacterial counts.
    Augustin JC; Carlier V
    Food Microbiol; 2006 Feb; 23(1):1-38. PubMed ID: 16942983
    [TBL] [Abstract][Full Text] [Related]  

  • 30. In-house quality assurance program in a state cytology laboratory.
    Gardner NM
    Acta Cytol; 1989; 33(4):487-8. PubMed ID: 2750439
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The quality of laboratory testing today: an assessment of sigma metrics for analytic quality using performance data from proficiency testing surveys and the CLIA criteria for acceptable performance.
    Westgard JO; Westgard SA
    Am J Clin Pathol; 2006 Mar; 125(3):343-54. PubMed ID: 16613337
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Impact of proficiency testing on results of the microscopic agglutination test for diagnosis of leptospirosis.
    Chappel RJ; Goris M; Palmer MF; Hartskeerl RA
    J Clin Microbiol; 2004 Dec; 42(12):5484-8. PubMed ID: 15583270
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Toward implementation of a regional quality assurance program in cytopathology: the Hong Kong experience.
    Ng WK; Chiu CS; Cheng Y; Chan ET; Chiu FL; Collins RJ;
    Acta Cytol; 2006; 50(2):164-77. PubMed ID: 16610684
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Reliability of white blood cell counting.
    Lohmann RC; Wood DE; Jacobs WI; Elliott ML
    Arch Pathol Lab Med; 1989 Sep; 113(9):989-94. PubMed ID: 2774866
    [TBL] [Abstract][Full Text] [Related]  

  • 35. European guidelines for quality assurance in cervical cancer screening: recommendations for cytology laboratories.
    Wiener HG; Klinkhamer P; Schenck U; Arbyn M; Bulten J; Bergeron C; Herbert A
    Cytopathology; 2007 Apr; 18(2):67-78. PubMed ID: 17397490
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Analysis of the intralaboratory diagnostic variability in the Imola cervical screening program].
    Fabbris E; Bucchi L; Folicaldi S; Amadori A; Ghidoni D; Medri M; Bondi A
    Pathologica; 1998 Apr; 90(2):127-32. PubMed ID: 9619055
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Implementation of proficiency testing in conjunction with a rechecking system for external quality assurance in tuberculosis laboratories in Mexico.
    Martinez-Guarneros A; Balandrano-Campos S; Solano-Ceh MA; Gonzalez-Dominguez F; Lipman HB; Ridderhof JC; Flisser A
    Int J Tuberc Lung Dis; 2003 Jun; 7(6):516-21. PubMed ID: 12797692
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Susceptibility testing practices for Streptococcus pneumoniae: results of a proficiency testing survey of clinical laboratories.
    Edson DC; Glick T; Massey LD
    Diagn Microbiol Infect Dis; 2006 Jul; 55(3):225-30. PubMed ID: 16545934
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Analysis of the results of the SEIMC External Quality Control Program for HIV-1 and HCV viral loads, 2007].
    ; Orta Mira N; Guna Serrano Mdel R; Latorre Martínez JC; Ovies MR; Pérez JL; Gimeno Cardona C
    Enferm Infecc Microbiol Clin; 2008 Nov; 26 Suppl 13():8-13. PubMed ID: 19100161
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Gynecologic cytology turnaround time. A College of American Pathologists Q-Probes Study of 371 laboratories.
    Jones BA; Valenstein PN; Steindel SJ
    Arch Pathol Lab Med; 1999 Aug; 123(8):682-6. PubMed ID: 10420223
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.